mohd izzuan
Shares of Bio-Techne Company (NASDAQ:TECH) traded larger after the life sciences firm topped analysts’ expectations with its Q2 FY25 outcomes, indicating a sooner topline progress amid early indicators of restoration within the biopharma finish market.
Minneapolis, Minnesota-based Bio-Techne (NASDAQ:
